{
    "2019-01-07": [
        [
            {
                "time": "",
                "original_text": "医疗保健：坚守低估值与确定性 荐7股",
                "features": {
                    "keywords": [
                        "医疗保健",
                        "低估值",
                        "确定性"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗保健"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业2019年度A+H策略报告:大破大立,不经一番寒彻骨,怎得梅花扑鼻香",
                "features": {
                    "keywords": [
                        "医药生物",
                        "2019年度",
                        "A+H策略",
                        "大破大立"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}